Comparison of the effect of minoxidil and spironolactone with minoxidil and finasteride in the treatment of Androgenic Alopecia
Phase 3
Recruiting
- Conditions
- Androgenic Alopecia.Androgenic alopecia
- Registration Number
- IRCT20211210053343N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
scalp involvement
aged 15-45 years
satisfaction to participate in the study
ability to follow the patient based on the doctor's diagnosis
normal hormonal tests
Exclusion Criteria
having an underlying disease
history of polycystic ovary syndrome
history of treatment in the last two months for the disease
contraindications to the use of spironolactone or finasteride such as pregnancy and lactation
concomitant use of drugs that may interact with the drugs under study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of alopecia. Timepoint: At the beginning of the study, 2 and 4 months later. Method of measurement: based on Ludwig grade by patient s physician.;Qualitative and quantitative severity of alopecia. Timepoint: At the beginning of the study, 2 and 4 months later. Method of measurement: based on clinical and dermatoscopic images by a blind dermatologist.;The rate of improvement. Timepoint: 2 and 4 months after the beginning of the treatment. Method of measurement: based on patient satisfaction scale.
- Secondary Outcome Measures
Name Time Method